Sofinnova Partners
Not publicly disclosed in the reviewed sources. · seed, series-a, growth · Europe, US
Europe-US life-sciences specialist with €4B+ AUM and a proposal-routing form.
Tier 2 · ranked #76europebio
Visit / pitchOfficial siteOpen in the live directory
Key facts
| Fund size | €4B+ AUM platform |
| Stage | seed, series-a, growth |
| Typical first check | Not publicly disclosed in the reviewed sources. |
| Sectors | bio, health, climate |
| Geography | Europe, US |
| Status | open |
Always confirm on the official page before applying — dates and terms change.
Background
Europe-US life-sciences specialist with €4B+ AUM and a proposal-routing form. This pass separates published fund behavior from private mechanics and catalog assumptions.
How the application really works
Submit through the official founder intake: https://sofinnovapartners.com/submit
Tips
- Show direct fit to seed / series-a / growth and the published thesis.
- Route to a named investor whose current remit matches the company.
- State geography, round size, traction and why this firm is the right partner.
Watch out for
- Outside the published stage, geography or sector mandate.
- Treating a generic media or LP channel as a founder intake.
- Assuming unpublished check, ownership or timing data.
Track record
- Official portfolio includes DBV Technologies, Coave Therapeutics and Enterome.
No comparable acceptance rate is published.
Investment thesis
Life sciences improving human and planetary health.
How to reach them
- Pitch submission form
- Submit through the official founder intake: https://sofinnovapartners.com/submit
Notable portfolio
DBV TechnologiesCoave TherapeuticsEnterome
Frequently asked questions
- What stages does the fund target?
- seed, series-a, growth
- Where does it invest?
- Europe, US
- What is the latest disclosed vehicle or capital base?
- €4B+ AUM platform
- What check size does it write?
- Not publicly disclosed in the reviewed sources.
- How can a founder approach the firm?
- Submit through the official founder intake: https://sofinnovapartners.com/submit
- What remains unknown?
- Investment acceptance rate is not published. latest fund size is not publicly disclosed. latest fund vintage is not publicly disclosed. check min is not publicly disclosed.
Related venture funds
Source Code CapitalUndisclosed. · China, with selective global exposureSignalFireNot publicly disclosed in the reviewed sources. · USSection 32Not publicly disclosed in the reviewed sources. · US, GlobalSozo VenturesUndisclosed. · US, Japan and global companies expanding into JapanSV Angel200,000–200,000 USD · US, Global selectivelyQiming Venture PartnersUndisclosed; no standardized check range was found. · China, with US and selective global reach
Sources
- www.sofinnovapartners.com/portfolio — Official fund source retained for thesis, portfolio, team, and status follow-up.; copied from Layer 1 and not re-fetched during baseline generation
- sofinnovapartners.com — Current official strategy, geography and activity. (checked 2026-08-10)
- sofinnovapartners.com/team — Current official investing-team roster. (checked 2026-08-10)
- sofinnovapartners.com/portfolio — Official portfolio and track-record evidence. (checked 2026-08-10)
- sofinnovapartners.com/submit — Official public founder or organization contact route. (checked 2026-08-10)